Browsing: Phase

Credit: Callista Images/Getty Images A once-daily, single-tablet regimen combining bictegravir and lenacapavir maintained viral suppression at rates comparable to complex…

Credit: Juan Gaertner / Science Photo Library / Getty Images In autoimmunity and immune-mediated disorders, fields long dominated by chronic…

Credit: wildpixel/Getty Images Cambridge biotech Microbiotica has achieved good results for its microbiome-based therapy for ulcerative colitis in a Phase…

Altimmune raises $75 million to advance pemvidutide, a promising therapy tackling serious liver and metabolic diseases. For most, liver disease…

Cardiff Oncology (NASDAQ: CRDF) this past week trumpeted positive data via press release from a Phase II trial of its…

Phase III trial shows up to 28.7% weight loss, but tolerability remains a key concern for Eli Lilly’s triple-agonist therapy.…

Credit: Mohammed Haneefa Nizamudeen/Getty Images Final results from a Phase I clinical study suggest that a preventive vaccine strategy for…

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both…

Early biomarker engagement and clean safety data position VNA-318 as a potential new entrant in longevity-focused neurotherapeutics. Vandria has reported…

More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ:…